Research Study

Canadian Non-Interventional Prospective Cohort Study on the Real - Life Assessment of Abilify Maintena ™ in Schizophrenia
Principal Investigator 
Soma Ganesan

Overview

Body Locations and Systems 
Brain
Disorders and Conditions 
Schizophrenia
ClinicalTrials.gov# 
NCT02131415
Status 
Closed to Recruitment
Study Start/End 
Oct 1, 2014 to Dec 1, 2016
Locations 
Vancouver Community
Name/Title 
Boris Feldman, Study Coordinator
Phone 
604-875-5823
Email Address 
boris.feldman@vch.ca
Purpose of Study 

This is a non-interventional, Canadian, study in patients treated with Abilify Maintena™ for schizophrenia followed for 24 months, with 9 visits recommended. Study assessments and administration of questionnaires will take place during the patient regular assessments or injection visits that are part of routine care. The main objective of the study is to describe the impact of treatment with Abilify Maintena™ on global functional status.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.